论文部分内容阅读
目的:讨论分析脑钠肽(BNP)、尿酸、乳酸脱氢酶(LDH)心肌钙蛋白T、总胆红素、间接胆红素检测指标在心血管疾病中的临床应用。方法:收集2016年2~7月期间心血管疾病住院患者(心血管疾病组)的6项指标的数据,同时收集同期住院其他科室非心血管疾病(非心血管疾病组)的6项指标的数据,通过统计学的方法,比较组间及组内(治疗前后)的差异有无统计学意义。结果:1心血管疾病组的各项指标明显高于非心血管疾病组,差异有统计学意义(P<0.05),以单个指标升高为主,而心血管疾病组多以3个或以上指标升高为主;2各心血管疾病组在治疗之后指标降低最明显的为BNP,且与第一次检测结果相比差异有统计学意义(P<0.05)。结论:多项指标检测在心血管疾病早期诊断、治疗及观察预后具有重要意义。
Objective: To discuss the clinical application of BNP, LDH cardiac troponin T, total bilirubin and indirect bilirubin in cardiovascular diseases. Methods: Data of 6 indicators of hospitalized patients with cardiovascular disease (cardiovascular disease group) from February to July 2016 were collected. Six indicators of non-cardiovascular disease (non-cardiovascular disease group) in other departments of hospitalized during the same period were collected Data, through statistical methods, between groups and within the group (before and after treatment) whether the difference was statistically significant. Results: 1 The indexes of cardiovascular disease group were significantly higher than those of non-cardiovascular disease group, the difference was statistically significant (P <0.05), with the single index increased, while the cardiovascular disease group more than 3 or more (P <0.05) .2 The levels of BNP decreased most significantly in each cardiovascular disease group after treatment. The difference was statistically significant (P <0.05) compared with the first test. Conclusion: The detection of multiple indicators in the early diagnosis and treatment of cardiovascular disease and prognosis of great significance.